Results 31 to 40 of about 105,136 (287)

Unfair Terms and Unpredictability in the Insurance Contract

open access: yesCECCAR Business Review
Unfair terms in insurance contracts are identified by courts of law, usually notified by the insured. The courts interpret the insurance policies clauses that are ambiguous, unclear, and even illegal.
Ioana Nely MILITARU
doaj   +1 more source

Comprehensive Diagnosis of Activity's Economic Indicators to Ensure Insurance Companies' Financial Security [PDF]

open access: yesОблік і фінанси
The development of the insurance market is accompanied by unstable transitional processes that can create threats and risks of worsening the insurer's financial condition.
Lada Shіrіnyan
doaj   +1 more source

Problematic Aspects in Developing Insurance of Enterprise Financial Risks [PDF]

open access: yesProblemi Ekonomiki, 2019
The aim of the article is to investigate, research and comprehensively solve problematic aspects in developing insurance of enterprise financial risk.
Tanchak Yaryna A., Mykolyshyn Martha M.
doaj   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham   +7 more
wiley   +1 more source

Trafik Sigortasında Dava Açılmadan Önce Sigortacı Tarafından Zarar Görene Yapılan Ödemenin Zamanaşımını Kesip Kesmediği Meselesi

open access: yesAnadolu Üniversitesi Hukuk Fakültesi Dergisi
Karayolları Trafik Kanunu’nun 97’nci maddesine göre zarar görenin, karayolları motorlu araçlar zorunlu mali sorumluluk sigortasında öngörülen sınırlar içinde sigortacıya karşı dava yoluna gitmeden önce ilgili sigortacıya yazılı başvuruda bulunması ...
Abdülhamid Oğuzhan Hacıömeroğlu
doaj   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund   +3 more
wiley   +1 more source

Maximum Market Price of Longevity Risk under Solvency Regimes: The Case of Solvency II. [PDF]

open access: yes, 2016
Longevity risk constitutes an important risk factor for life insurance companies, and it can be managed through longevity-linked securities. The market of longevity-linked securities is at present far from being complete and does not allow finding a ...
Helena Leino-Kilpi (3471101)   +5 more
core   +5 more sources

Hospital Readmission After Traumatic Brain Injury Hospitalization in Community‐Dwelling Older Adults

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the risk of hospital readmission after an index hospitalization for TBI in older adults. Methods Using data from the Atherosclerosis Risk in Communities (ARIC) study, we used propensity score matching of individuals with an index TBI‐related hospitalization to individuals with (1) non‐TBI hospitalizations (primary analysis)
Rachel Thomas   +7 more
wiley   +1 more source

Workmen’s Compensation Insurer as Suable Third Party [PDF]

open access: yes, 1969
Until 1960, lawyers appeared to assume that the workmen\u27s compensation insurance carrier partook of the employer\u27s immunity to common law suit by an injured employee.
Larson, Arthur
core   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Home - About - Disclaimer - Privacy